Emily is a partner in the firm's Advocacy Group. She provides advice and representation to stakeholders in various regulated industries, with specific expertise working with Health Canada-regulated clients. She has experience advising on all manner of regulatory issues, risk management and policy matters and applies her regulatory expertise to product liability and class action litigation.
Among other things, Emily has worked with clients:
· Providing advice on Health Canada regulatory issues, including pharmaceutical, medical device, food and natural health product marketing compliance, labeling, licensing, and mandatory problem and adverse event reporting;
· Outlining the implications of legislative change in areas such as health information privacy, the Canada Consumer Product Safety Act, and the Ontario Drug Benefit Program;
· Making and responding to federal and provincial access to information requests;
· Advising foreign companies entering the Canadian products market on licensing and other regulatory requirements;
· Advising on product liability issues, such as risk management measures, managing recalls, and defending individual and class action litigation.
Emily developed an interest in health law issues through her experiences at the Consent and Capacity Board and with the College of Nurses of Ontario. This interest has been further developed through an in-house secondment with the legal department of a multinational pharmaceutical company.
As a member of the firm's Risk Management Committee, Emily is well versed in developing practical and proactive solutions to manage and prevent risk exposure through policy development, implementation of best practices and maximizing the use of technologies.
Emily is on the Editorial Board of Class Action Journal. She has published and spoken on a variety of topics including the reuse of single-use medical devices, national class actions, natural health product marketing, incorporation by health professionals, spoliation, cross-border discovery and access to information requests.
Associations
· Canadian Bar Association
· Defence Research Institute
· Ontario Bar Association (Vice-Chair, Health Law Section)
· The Advocates' Society
· Toronto Lawyers Association
In The News
Canadian Women Targeted for Free Sperm Donations
Emily Larose Helps MEDEC to Persuade Health Canada to Change Position on e-Labelling of Medical Devices
Presentations
03/12/2012, Reprocessing/Refurbishing Regulated Products: MEDEC 2011 MedTech Conference
05/26/2011, Strategies for Effective On-site Medical Device Development and Device Modification
05/02/2011, Consumer Product Safety Case Law Update: Government Negligence and other Recent Trends in Product Liability
03/15/2011, A Canadian Legal Primer on Medical Device Regulation in Canada
11/03/2010, Legal Implications of Reprocessing Single Use Devices
12/04/2008, Marketing Compliance
11/14/2008, Legal Issues in Pharmacovigilance - 2008
10/30/2008, Product Safety, Adverse Events - Legal Responsibilities and Liabilities
11/16/2007, Legal Issues in Pharmacovigilance
10/24/2007, Industry Codes of Conduct
09/19/2005, Chaoulli: Two Tiers or To Tears?
11/30/2004, Analysis of Health Canada's Requirements in Numerous Areas including the New Health Protection Act
12/10/2003, Cassels Brock Speaks at MEDEC Legal Issues Seminar
Articles
Emily Larose Co-Authors Article on Post-Market Surveillance and Medical Device Manufacturers' Obligations for Medec Pulse, 11/11/2011
Regulation of Assisted Human Reproductive Treatments in Canada - the Assisted Human Reproduction Act, 11/11/2011
Emily Larose Co-Authors Article on Incorporation of Health Professionals for Medec Pulse, 11/11/2011
Cross-Border Discovery: A Case Comment on #771/99 Glen Ford v. F. Hoffman-LaRoche Ltd. et al and #99-GD-46719 VitaPharm Canada Ltd. et al v. F. Hoffman-LaRoche Ltd. et al, 11/11/2011
Liability Perspectives on Reuse of Single-Use Medical Devices, 11/11/2011
The Canada Consumer Product Safety Act: A New Regime of Consumer Product Oversight Throughout the Supply Chain, 11/11/2011
New Rulings, No Solutions; An Update on National Class Actions Jurisprudence, 07/14/2009
Revising Premarket Notification: The Canadian Process as a Model, 07/14/2009
Too Much Information: Handling Access to Information Requests, 10/16/2008
Canada: Legislation Introduced To Modernize The Food And Drugs Act And Permit Recalls Of Unsafe Consumer Products, 04/23/2008
Right Drug, Right Person, Right Price: Improving and Governing the Provincial Drug System, 01/01/2006
Tampering with the Evidence, 01/01/2006
Newsletters
Life Sciences Group e-LERT: Supreme Court Rules on Scope of PMPRB Authority, 01/21/2011
Transactions
Cassels Brock Represents Alexion Pharmaceuticals, Inc. in Its Approximately $1.08 Billion Acquisition of Enobia Pharma Corp., 02/28/2012
Jail Time for Contemptuous Infringement Following Receipt of Injunction Order by Email, 02/14/2006